Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema (DME) ...

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of ...

How can you create a device that can test Indians’ eyes without dilating them? This was the question K Chandrasekhar (KC) and ...

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of ...

Dr. Frenkel highlights a comprehensive program that covers the latest breakthroughs in glaucoma and cataract surgery to in-depth discussions on AI, retinal treatments, and new drug-delivery platforms, ...

REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with ...

Diabetic retinopathy is a common complication in people with type 1 and type 2 diabetes, progressing from mild, moderate, and ...

International Assets Investment Management LLC decreased its holdings in shares of Regeneron Pharmaceuticals, Inc.

French biochemist Jessie Inchauspé is sharing her tips to lower blood glucose levels, as part of her new Channel 4 show.

Diversified Trust Co grew its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 93.0% in the fourth quarter, according to the company in its most recent filing with the ...

The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving ...

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...